In Vitro Evaluation of Poly ε-Caprolactone/Hydroxyapatite Composite as Scaffolds for Bone Tissue Engineering with Human Bone Marrow Stromal Cells

Abstract:

Article Preview

This study evaluated the potential of the PCL (poly -caprolactone)/HA(Hydroxyapatite) composite materials as a scaffold for bone regeneration. For this, we fabricated scaffolds utilizing salt leaching method. The PCL/HA composite scaffolds were prepared with various HA contents (20wt%, 40wt%, 60 wt %). To ensure the potential for the scaffolds, porosity tests were conducted along with SEM observations. The porosity decreased with the increase of the contents of HA particles. The porosity of the composite with the highest contents of HA was still adoptable (~85%). In addition, the PCL/HA composite scaffolds were evaluated for their ability of osteogenic differentiation with human bone marrow stromal cell (hBMSC) in vitro. Alkaline phosphatase (ALP) activity, markers for osteoblastic differentiation, and total protein contents were evaluated in hBMSCs following 14 days of cultivation. The addition of HA particles enhanced proliferation of hBMSC during the test. Also, the differentiation ability of the cells was increased as HA particles were added. In this study, we concluded that PCL/HA composite scaffolds has great potential as a scaffold for bone tissue engineering.

Info:

Periodical:

Key Engineering Materials (Volumes 342-343)

Edited by:

Young-Ha Kim, Chong-Su Cho, Inn-Kyu Kang, Suk Young Kim and Oh Hyeong Kwon

Pages:

369-372

DOI:

10.4028/www.scientific.net/KEM.342-343.369

Citation:

S.J. Heo et al., "In Vitro Evaluation of Poly ε-Caprolactone/Hydroxyapatite Composite as Scaffolds for Bone Tissue Engineering with Human Bone Marrow Stromal Cells ", Key Engineering Materials, Vols. 342-343, pp. 369-372, 2007

Online since:

July 2007

Export:

Price:

$38.00

[1] A. R. Gazdag, J. M. Lane, D. Glaser et al.: J Am Acad Orthop Surg., Vol. 3 (1995), pp.1-8.

[2] Kneser, D. J. Schaefer et al. Tissue engineering of bone, Vol. 10(2006), pp.7-9.

[3] C. R. Perry: Clin Plast Surg., Vol. 360, pp.71-86.

[4] A. R. Derubesis, R. Cancedda: Annals of biomedical Eng., Vol. 32 (2004), pp.160-165.

[5] R. Cancedda, G. Bianchi et al.: Stem cells, Vol. 21(2003), pp.610-619.

[6] J. Reignier, M. A. Huneault: Polymer, Vol. 47(2006), pp.4709-4717.

[7] J. R. Mauney, C. Jaquiery, V. Volloch et al.: Biomaterials, Vol. 26 (2005), pp.3173-3185.

[8] D. Rohner, D.W. Huntmacher, T.K. Cheng et al.: J Biomed Mater Res., Vol. 66 (2003), pp.574-580.

[9] H.Y. Kweon, Yoo M.K., Park I.K. et al.: Biomaterials, Vol. 24 (2003), pp.801-808.

[10] Marra K. G., Szem J.W., Kumta P.N. et al.: J Biomed Mater Res., Vol. 47 (1999), pp.324-335.

[11] H. W. Kim, J. C. Knowles et al.: Biomaterials, Vol. 25(2004), pp.1279-1287.

[12] D. Turhani, E. Watzinger et al.: Clin. Oral Impl. Res., Vol. 16(2005), pp.417-424..

In order to see related information, you need to Login.